Confirmed speakers (in alphabetical order):
Rafael Cayuela, Dow (Switzerland)
Peter Flippo, BioProcess Facility (Netherlands)
Daniel MacEachran, Braskem (Brazil)
Dan currently serves as the Head of Open Innovation for Braskem’s Renewable Chemicals and Materials group. In this role, he and his team are responsible for accelerating the flow of new technologies into and through Braskem’s Renewables R&D pipeline via the identification and participation in mutually beneficial collaborations. Prior to joining Braskem, Dan served as the Director of Research and Development at Greenlight Biosciences where he led efforts to identify new applications for Greenlight’s RNA production process as well as their cell free production platform more broadly. Dan also worked as a senior metabolic engineer at Logos Technologies, developing new renewable fuels and chemicals technologies. Dan earned his PhD from Dartmouth Medical School in the field of Microbiology and Immunology and received further training as a Postdoctoral Researcher at the Massachusetts Institute of Technology working with Tony Sinskey.
Topic of presentation: Commercializing biosourced commodity chemicals: lessons learned and what’s next
Stefano Nigro, Italian Trade Agency (ITA)
Stefano is the Director of the Foreign Investment Department at ITA Agency. ITA acts on behalf of the Italian Government to promote FDI to Italy and to support foreign investors. He has a 10 year experience of investment promotion: before joining ITA, he was the head of the Investment Promotion Department of the Lombardy Region, the main business area in Italy, accounting for 20% of the Italian GDP and hosting more than 60% of foreign companies in the Country. He was previously involved in Strategy & operation consultancy. He holds an M.Sc. in Economics from Warwick University.